Diagnostics & prognostics

Disease Area Diagnostics & prognostics

Beating the Clock in Brain Injury

| Roisin McGuigan

Diagnosis and prognosis of brain injury can be complex – but is simple blood test on the horizon?

Tools & Techniques Cancer

Rush at Your Peril

| Eleftherios P. Diamandis

False discoveries have plagued biomarker research for years: don't trust everything you read.

Tools & Techniques Analytical science

The Hunt for an HD Blood Test

| Roisin McGuigan

Do we finally have an effective blood biomarker for studying progression of Huntington’s disease?

Tools & Techniques Immunology

The ABCs of Autoimmunity

| Michael Schubert

A unique type of B cell appears to play a role in the development of autoimmune disorders.

Tools & Techniques Analytical science

The Importance of Chiral Metabolomics

| Tomonori Kimura

Could chiral amino acids function as biomarkers for kidney disease?

Tools & Techniques Cancer

CEA: Overlooked and Underused

| Roisin McGuigan

Could an existing blood test improve treatment choices – and outcomes – for some colon cancer patients?

Disease Area Public health

Hurdles to HIV Survival

| Roisin McGuigan

Why are so many patients with HIV still dying too young?

Research Field Diagnostics & prognostics

Cracking a Cold Case

| Roisin McGuigan

A 30-year-old medical puzzle leads researchers to develop a new molecular therapy.

Tools & Techniques Cancer

The Rise of ctDNA, Part Two

| Michael Schubert

Circulating tumor DNA profiling can yield new insights into early-stage lung cancer evolution.

Tools & Techniques Cancer

The Rise of ctDNA, Part One

| Roisin McGuigan

New ctDNA assays could make more metastatic melanoma cases detectable.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register